Search alternatives:
significant progressive » significant progress (Expand Search), significant protective (Expand Search), significant processes (Expand Search)
progressive decrease » progressive decline (Expand Search)
small decrease » small increased (Expand Search)
point decrease » point increase (Expand Search)
Showing 21 - 40 results of 4,505 for search '(( significant progressive decrease ) OR ( significant ((small decrease) OR (point decrease)) ))', query time: 0.60s Refine Results
  1. 21
    <sup>13</sup>C NMR spectra for Kylo-0603.

    <sup>13</sup>C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 22
    General procedure for the synthesis of A and A-c1.

    General procedure for the synthesis of A and A-c1. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 23
    Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603 (0.1–10 mg/kg/day, as indicated).

    Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603... by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 24
    DIO Mice Liver Staining.

    DIO Mice Liver Staining. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 25
    Trends of peroxisome-related gene expression in liver tissue.

    Trends of peroxisome-related gene expression in liver tissue. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 26
    NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day).

    NAS (NAFLD Activity Score) of liver tissue of mice in each group after 8 weeks of treatment with either vehicle (V) or Kylo-0603 (0.1-10 mg/kg/day). by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 27
    The body weight and cholesterol levels of the mice were recorded before the administration of the drug.

    The body weight and cholesterol levels of the mice were recorded before the administration of the drug. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 28
    Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combined with digital image analysis technique.

    Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine... by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 29
    The structures of T3 and Kylo-0603.

    The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 30
    Synthesis process of Kylo-0603.

    Synthesis process of Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 31
    ESI-HRMS spectra for Kylo-0603.

    ESI-HRMS spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 32
    General procedure for the synthesis of Kylo-0603.

    General procedure for the synthesis of Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 33
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 34
    Agreement between microscopy and qPCR analysis of MarBTN progression.

    Agreement between microscopy and qPCR analysis of MarBTN progression. by Rachael M. Giersch (22331947)

    Published 2025
    Save to List
    Saved in:
  15. 35
    Detection of MarBTN-specific eDNA in tank water at late stages of MarBTN progression.

    Detection of MarBTN-specific eDNA in tank water at late stages of MarBTN progression. by Rachael M. Giersch (22331947)

    Published 2025
    Save to List
    Saved in:
  16. 36
    Immunogenicity results of different vaccination schemes at different time points.

    Immunogenicity results of different vaccination schemes at different time points. by Rima Moghnieh (679199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 37
    Time course of Path Length, LFS and Velocity during postural training.

    Time course of Path Length, LFS and Velocity during postural training. by Cristina Dolciotti (16317330)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 38
    Time course of 95% Area, X and Y Amplitude Sway during postural training.

    Time course of 95% Area, X and Y Amplitude Sway during postural training. by Cristina Dolciotti (16317330)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 39
    Between-group differences in 95% Area, Y Sway Amplitude and LFS during postural training.

    Between-group differences in 95% Area, Y Sway Amplitude and LFS during postural training. by Cristina Dolciotti (16317330)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 40
    Relation between training-related changes in unipedal and bipedal stance.

    Relation between training-related changes in unipedal and bipedal stance. by Cristina Dolciotti (16317330)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: